Qian Li

Associate Chief Physician, Department of Hematology, Tianjin Medical University Cancer Hospital

Attending Physician, Blood Transplant Department, Airport Hospital, Tianjin Cancer Hospital

Master’s Thesis Supervisor, Peking Union Medical College

Member of the Standing Committee, Physicians Branch, Tianjin Medical and Health Education Association

Member of the Standing Committee, Health Education and Management Professional Committee, Tianjin Medical and Health Society

Member of the Standing Committee, Hematology Professional Committee, Beijing Chronic Disease Prevention and Health Education Research Association

Proficient in the diagnosis and treatment of hematologic malignancies, including multiple myeloma, lymphoma, leukemia, and neuroblastoma.

Extensive experience in autologous hematopoietic stem cell transplantation and CAR-T therapy for refractory and relapsed hematologic diseases.

Skilled in managing complex cases of hematologic disorders, integrating cutting-edge therapies such as immunotherapy and targeted treatment.

Over a decade of clinical practice in hematology, focusing on high-risk hematologic malignancies.

Successfully performed autologous hematopoietic stem cell transplantation for multiple myeloma and lymphoma patients.

Actively involved in clinical applications of CAR-T therapy, contributing to improved outcomes in relapsed leukemia and lymphoma cases.

Principal investigator of a National Natural Science Foundation of China Youth Project, focusing on novel therapeutic strategies for hematologic malignancies.

Published more than 10 SCI papers as the first author, emphasizing advancements in multiple myeloma, lymphoma, and CAR-T therapy.

Research interests include translational studies in cellular immunotherapy (CAR-T), gene therapy, and personalized treatment protocols for hematologic diseases.